Stocks to sell

Real estate boom-and-bust cycles are repetitive, and I’m afraid that we look set for another. What’s my premise? Well, the interest-rate cycle has topped out, and the U.S. Treasury yield curve is inverted, which usually means an economic slowdown is set to occur. Moreover, commercial real estate prices are on a steep decline while mortgage rates remain exorbitant. Real Estate Investment
As you may recall from my past coverage of Rivian Automotive (NASDAQ:RIVN), I’ve been bearish about this early-stage electric vehicle stock. However, following the EV maker’s latest quarterly earnings release, my RIVN stock analysis has become even more downbeat. Why? Admittedly, Rivian remains in a much better position than other high-profile EV upstarts. For instance,
With the stock market reaching new record highs, the list of stocks to sell grows. Driven in part by expectations around artificial intelligence (AI) developments, several companies have become significantly overextended relative to their underlying financial performance. While broader economic and monetary conditions support ongoing gains across indices, not all firms will be wise long-term
Hindenburg Research may be the most famous activist short-selling investment research firm in recent history. Where many short sellers run their due diligence, develop a trade thesis and execute behind the scenes, Hindenburg is happy to bring ts research to wider market attention. Hindenburg was instrumental in highlighting Nikola’s (NASDAQ:NKLA) blatant fraud and Adani Group’s
Steel prices are trading under pressure in 2024 with VanEck Steel ETF (NYSEARCA:SLX) down about 4% year-to-date. This has promoted commodity investors to draw a list of stocks to avoid in this space.  The latest data shows that China’s crude steel output remained unchanged in 2023 compared to the previous year, marking a stabilization after
Both Advanced Micro Devices (NASDAQ:AMD) stock and Nvidia (NASDAQ:NVDA) have each hit their respective highs in the past year with AMD being up 115% and NVDA 236% over the past year. This has been to due the massive innovation taking place over the past year with the growth of AI.  However, AMD stock does not
The unpredictability of the biotech sector, highlights the inherent risks involved in certain biotech stocks to sell. 2023 was a rough year for the market, marked by a 10% plunge in the SPDR S&P Biotech ETF (XBI), alongside widespread layoffs and fundraising challenges. Moreover, despite forecasts pointing to a potential rebound in 2024, the biotech
California-based Lucid Group (NASDAQ:LCID) has provided investors with plenty of disappointment recently, as the company showcased lower-than-expectations earnings in its recent report. Fourth quarter data showed deliveries growth came in at only at 10%, and production also declined by 32%. Alongside these numbers, revenue also did not reach expectations, which came in at $137.8 million,